Analyst firms · H.C. Wainwright · BMEA
H.C. Wainwright BMEA price target and rating history
Biomea Fusion Inc. (BMEA) · Health Care
H.C. Wainwright rates Biomea Fusion Inc. (BMEA) Buy with a $44 price target, as of its latest action on Mar 28, 2023. It has published 3 rating actions on BMEA since January 2022, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $44
- Median target, all firms
- Too few
- Actions on BMEA
- 3
H.C. Wainwright price target on BMEA
Every H.C. Wainwright rating on BMEA
- Mar 28, 2023
- Jun 2, 2022
- Jan 12, 2022
Questions about H.C. Wainwright and BMEA
- What is H.C. Wainwright's price target for BMEA?
- H.C. Wainwright's latest stated price target for Biomea Fusion Inc. (BMEA) is $44, from its action on Mar 28, 2023.
- What is H.C. Wainwright's rating on BMEA?
- H.C. Wainwright rates BMEA Buy, a bullish rating, as of Mar 28, 2023.
- When did H.C. Wainwright last change its view on BMEA?
- On Mar 28, 2023, H.C. Wainwright raises its price target to $44 from $37, keeps Buy.
More BMEA rating histories
All H.C. Wainwright ratingsBMEA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.